ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
3,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
7,1,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
8,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
9,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
10,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
10,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
11,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
11,2,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
11,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
11,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
11,5,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
11,6,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
11,7,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
12,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
13,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
14,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
14,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
15,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
16,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
17,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
18,1,Radiation pneumonitis,Radiation injuries,Injuries by physical agents,Inj&P,N
19,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
20,1,Headache,Headaches NEC,Headaches,Nerv,N
20,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
21,1,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
22,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
23,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,Y
24,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
24,2,Embolism arterial,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
24,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
24,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
24,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,1,Recall phenomenon,Skin procedural complications,Procedural related injuries and complications NEC,Inj&P,N
26,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
27,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
27,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
27,3,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
27,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
28,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
28,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,Y
28,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
29,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
29,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
29,3,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
30,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
30,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
31,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
32,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
32,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
33,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
34,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
34,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
34,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
35,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
36,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
36,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
36,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
36,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
37,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
37,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
38,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
38,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
39,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
39,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
39,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
40,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
41,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
41,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
41,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
42,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
43,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
43,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
44,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
45,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
45,2,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
45,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
45,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
46,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
46,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
47,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
48,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
49,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
49,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
49,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
49,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
50,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
50,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
50,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
51,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
51,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
52,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
52,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
53,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
54,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
54,2,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
54,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
55,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
56,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
57,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
57,2,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
57,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
57,4,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
58,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
59,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
60,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
61,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
61,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
61,3,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
62,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
63,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
63,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
64,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
65,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
65,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
65,3,Paraneoplastic syndrome,Paraneoplastic syndromes NEC,Neoplasm related morbidities,Neopl,N
65,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
66,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
66,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
66,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
67,1,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
68,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
68,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
69,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
69,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
69,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
70,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
70,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
70,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
70,4,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
70,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
71,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
72,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
73,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,Y
74,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
74,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
75,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
76,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
77,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
77,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
78,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
79,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
80,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
80,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
81,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
82,1,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
83,1,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
83,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
84,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
84,2,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
84,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
84,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
84,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
85,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
85,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
85,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
85,4,Headache,Headaches NEC,Headaches,Nerv,N
86,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
86,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
87,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
88,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
89,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
89,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
90,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
90,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
90,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
90,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
90,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
91,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
91,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
91,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
92,1,Vascular pain,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
93,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
93,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
94,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
94,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
94,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
94,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
95,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
95,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
95,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
96,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
97,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
97,2,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
98,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
98,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
98,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
99,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
100,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
101,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
102,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
103,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
103,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
103,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
103,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
104,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
105,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
106,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
106,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
106,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
107,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
108,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
108,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
109,1,Extremity necrosis,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
110,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
111,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
111,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
112,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
112,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
113,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
114,1,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
114,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
115,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
115,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
116,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
116,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
117,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
118,1,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
119,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
120,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
120,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
121,1,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
121,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
122,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
123,1,Liver abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,Y
123,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
123,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
124,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
124,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
125,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
126,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
126,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
126,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
126,4,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
126,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
126,6,Supraventricular extrasystoles,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
127,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
127,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
128,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
128,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
128,3,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,Y
128,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
128,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
129,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
129,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
130,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
130,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
131,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
131,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
132,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
133,1,Bladder dysfunction,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
134,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
134,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
135,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
135,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
136,1,Listeriosis,Listeria infections,Bacterial infectious disorders,Infec,N
136,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
137,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
138,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
139,1,Headache,Headaches NEC,Headaches,Nerv,N
139,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
139,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
140,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
140,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
140,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
141,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
142,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
142,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
142,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
143,1,Angina unstable,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
144,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
145,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
146,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
147,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
147,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
148,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
149,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
150,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
150,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
151,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
152,1,Biliary obstruction,Obstructive bile duct disorders (excl neoplasms),Bile duct disorders,Hepat,N
152,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
152,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
153,1,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
154,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
155,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
156,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,Y
156,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
156,3,Recall phenomenon,Skin procedural complications,Procedural related injuries and complications NEC,Inj&P,N
157,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
158,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
159,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
160,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
161,1,Alopecia totalis,Alopecias,Skin appendage conditions,Skin,N
161,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
161,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
161,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
161,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
162,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
163,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
163,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
163,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
163,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
164,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
165,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
166,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
166,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
167,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
167,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
167,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
168,1,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
169,1,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
170,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
171,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
171,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
171,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
171,4,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
172,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
173,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
174,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
175,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
176,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
176,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
176,3,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
176,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
176,5,Headache,Headaches NEC,Headaches,Nerv,N
176,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
177,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
177,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
177,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
177,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
177,5,Laryngeal oedema,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
177,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
177,7,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
177,8,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
178,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
178,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
179,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
180,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
180,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
180,3,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
180,4,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
180,5,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
180,6,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
180,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
181,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
181,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
182,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
183,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
184,1,Magnetic resonance imaging head abnormal,Central nervous system imaging procedures,"Neurological, special senses and psychiatric investigations",Inv,N
184,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
185,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
186,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
186,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
187,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
188,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
188,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
189,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
189,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
189,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
189,4,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
190,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
190,2,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
191,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
192,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
192,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
193,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
193,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
194,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
194,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
195,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
196,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
197,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
198,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
198,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
199,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
199,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
200,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
201,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
202,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
202,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
203,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
204,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
205,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
205,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
205,3,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
205,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
206,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
206,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
206,3,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
207,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
207,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
207,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
208,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
208,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
209,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
209,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
210,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
211,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
212,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
212,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
213,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
214,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
215,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
216,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
217,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
218,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
218,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
218,3,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
219,1,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
220,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
220,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
220,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
220,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
220,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
220,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
220,7,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
220,8,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
220,9,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
221,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
221,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
221,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
221,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
221,5,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
222,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
222,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
222,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
223,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
223,2,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
223,3,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
224,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
224,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
225,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
225,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
226,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
226,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
226,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
226,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
226,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
226,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
226,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
226,8,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
226,9,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
226,10,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
226,11,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
226,12,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
226,13,Squamous cell carcinoma of lung,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
227,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
227,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
228,1,Abnormal clotting factor,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
228,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
228,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
228,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
228,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
228,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
228,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
228,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
229,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
229,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
230,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
230,2,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
230,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
230,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
231,1,Cryoglobulinaemia,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
231,2,Device occlusion,Device malfunction events NEC,Device issues,Prod,N
231,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
231,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
231,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
232,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
232,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
232,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
232,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
233,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,Y
233,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
233,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
233,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
234,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
235,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
235,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
235,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
236,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
236,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
236,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
237,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
237,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
237,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
238,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
238,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
238,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
239,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
239,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
239,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
240,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
240,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
240,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
241,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
241,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
241,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
242,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
242,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
242,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
243,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
244,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
245,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
245,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
245,3,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
245,4,Headache,Headaches NEC,Headaches,Nerv,N
245,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
245,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
246,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
247,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
247,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
248,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
248,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
248,3,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
248,4,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
248,5,Traumatic lung injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
249,1,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
250,1,Cholangiocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,Y
250,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
251,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
252,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
252,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
253,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
253,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
253,3,Foetal-maternal haemorrhage,Foetal complications NEC,Foetal complications,Preg,N
253,4,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
253,5,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
253,6,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
253,7,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
254,1,Increased bronchial secretion,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
254,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
255,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
256,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
256,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
257,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
258,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
259,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
260,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
260,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
261,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
262,1,Ovarian failure,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
263,1,Atrial tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
264,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
265,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
266,1,Tachyarrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
267,1,Arrhythmia supraventricular,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
268,1,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
268,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
269,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
269,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
269,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
270,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
271,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
272,1,Carbohydrate antigen 19-9 increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
272,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
272,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
272,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
272,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
272,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
273,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
274,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
275,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
275,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
276,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
276,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
277,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
277,2,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
277,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
278,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
278,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
278,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
279,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
279,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
280,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
280,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
281,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
281,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
282,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
282,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
283,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
283,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
284,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
284,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
285,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
285,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
286,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
286,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
287,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
287,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
288,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
289,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
290,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
290,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
291,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
292,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
293,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
294,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
294,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
295,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
296,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
297,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
298,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
299,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
300,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
301,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
301,2,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
301,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
301,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
301,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
302,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
302,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
302,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
302,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
303,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
303,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
303,3,Glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
303,4,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
303,5,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
304,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
305,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
306,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
307,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
307,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
308,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
309,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
310,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
311,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
312,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
313,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
314,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
315,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
315,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
316,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
317,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
317,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
318,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
319,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
320,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
321,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
322,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
323,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
324,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
325,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
326,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
327,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
328,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
329,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
330,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
330,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
331,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
332,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
333,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
334,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
335,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
336,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
337,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
338,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
339,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
339,2,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
340,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
340,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
340,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
340,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
340,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
341,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
341,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
341,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
341,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
342,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
342,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
342,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
342,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
343,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
344,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
345,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
346,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
347,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
348,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
349,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
350,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
351,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
352,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
353,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
354,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
355,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
356,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
357,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
358,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
359,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
360,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
361,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
362,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
363,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
364,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
365,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
366,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
367,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
368,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
369,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
370,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
371,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
372,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
373,1,Cerebral ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
373,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
374,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
374,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
374,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
375,1,Angiosarcoma,Cardiovascular neoplasms malignant and unspecified,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
375,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
375,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
375,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
375,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
375,6,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
376,1,Angiosarcoma,Cardiovascular neoplasms malignant and unspecified,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
376,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
376,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
377,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
377,2,Troponin I increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
378,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
378,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
379,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
379,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
380,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
381,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
381,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
381,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
381,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
381,5,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
382,1,Splinter haemorrhages,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
383,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
384,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
384,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
385,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
386,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
386,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
386,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
387,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
387,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
388,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
388,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
388,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
388,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
388,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
388,6,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
389,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
390,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
390,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
390,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
391,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
391,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
391,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
391,4,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
391,5,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
391,6,Histiocytic necrotising lymphadenitis,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
391,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
391,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
391,9,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
391,10,Paraneoplastic syndrome,Paraneoplastic syndromes NEC,Neoplasm related morbidities,Neopl,N
391,11,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
391,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
391,13,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
391,14,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
391,15,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
392,1,Paraneoplastic syndrome,Paraneoplastic syndromes NEC,Neoplasm related morbidities,Neopl,N
393,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
394,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,Y
395,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,Y
396,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,Y
397,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,Y
398,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
399,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,Y
400,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
401,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
402,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
403,1,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
403,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
404,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
404,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
405,1,Cerebellar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
405,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
406,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
406,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
406,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
406,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
406,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
406,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
406,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
407,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
407,2,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
408,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
408,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
408,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
408,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
409,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
409,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
409,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
409,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
410,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
410,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
411,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
411,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
411,3,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
411,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
411,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
411,6,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
412,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
412,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
412,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
412,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
413,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
413,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
413,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
413,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
414,1,Cerebral ischaemia,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
414,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
414,3,IIIrd nerve paresis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
415,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
416,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
417,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
418,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
419,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
419,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
419,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
419,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
419,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
420,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
420,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
420,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
421,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
421,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
422,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
422,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
423,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
423,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
423,3,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
423,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
423,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
423,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
423,7,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
423,8,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
423,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
424,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
425,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
426,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
426,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
426,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
427,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
427,2,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
428,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
429,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
430,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
431,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
431,2,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
432,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
433,1,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
434,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
434,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
435,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
436,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
436,2,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
437,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
438,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
438,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
439,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
439,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
439,3,Biliary sepsis,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
439,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
439,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
439,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
440,1,Biliary dilatation,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
440,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
440,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
440,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
441,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
441,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
441,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
441,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
442,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
443,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
444,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
444,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
444,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
445,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
445,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
445,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
445,4,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
445,5,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
445,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
445,7,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
446,1,Muscle necrosis,Myopathies,Muscle disorders,Musc,N
446,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
446,3,Recall phenomenon,Skin procedural complications,Procedural related injuries and complications NEC,Inj&P,N
447,1,Acute graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
447,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
447,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
447,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
447,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
447,6,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
447,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
447,8,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
447,9,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
447,10,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
447,11,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
447,12,Peripheral T-cell lymphoma unspecified recurrent,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,N
447,13,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
447,14,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
447,15,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
448,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
448,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
449,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
450,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
451,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
452,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
452,2,Arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
452,3,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
453,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
453,2,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
453,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
453,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
453,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
453,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
453,7,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
454,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
454,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
454,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
454,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
455,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
455,2,Infected dermal cyst,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
455,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
455,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
455,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
456,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
457,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
458,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
459,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
460,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
461,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
461,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
462,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
462,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
462,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
463,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
463,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
463,3,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
464,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
465,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
466,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
466,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
466,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
466,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
466,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
467,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
467,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
467,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
467,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
467,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
468,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,Y
468,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
468,3,Recall phenomenon,Skin procedural complications,Procedural related injuries and complications NEC,Inj&P,N
469,1,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
469,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
470,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
470,2,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
471,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
472,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
472,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
472,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
473,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
473,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
473,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
473,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
473,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
474,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
474,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
474,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
475,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
475,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
475,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
476,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
476,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
476,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
477,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,Y
478,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
479,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
480,1,Bile duct cancer,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
480,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
481,1,Bile duct cancer,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
481,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
481,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
482,1,Bile duct cancer,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
482,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
482,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
483,1,Bile duct cancer,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
483,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
483,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
484,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
484,2,Gallbladder neoplasm,Hepatobiliary neoplasms malignancy unspecified,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
484,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
485,1,Bile duct cancer,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
485,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
485,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
486,1,Bile duct cancer,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
486,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
486,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
486,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
486,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
486,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
486,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
486,8,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
487,1,Bile duct cancer,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
487,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
487,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
487,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
488,1,Bile duct cancer,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
488,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
488,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
489,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
489,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
490,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
490,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
490,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
491,1,Urinary bladder toxicity,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
492,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
492,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
492,3,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
492,4,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
492,5,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
493,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
493,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
493,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
494,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
494,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
495,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
495,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
495,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
495,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
496,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
497,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
497,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
497,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
498,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
499,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
500,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
500,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
500,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
500,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
500,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
500,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
500,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
500,8,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
500,9,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
500,10,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
500,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
501,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
502,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
502,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
502,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
502,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
503,1,Allergy to chemicals,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
503,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
503,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
503,4,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
503,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
503,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
503,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
503,8,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
503,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
503,10,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
503,11,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
503,12,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
503,13,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
503,14,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
503,15,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
503,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
503,17,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
503,18,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
503,19,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
503,20,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
503,21,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
503,22,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
503,23,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
503,24,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
503,25,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
503,26,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
503,27,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
503,28,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
503,29,Wound haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
503,30,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
504,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
504,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
504,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
505,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
505,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
506,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
506,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
507,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
508,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
508,2,Azotaemia,Renal failure complications,Renal disorders (excl nephropathies),Renal,N
508,3,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
509,1,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
510,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
511,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
512,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
512,2,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
512,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
513,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
513,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
513,3,Histiocytic necrotising lymphadenitis,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
513,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
513,5,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
513,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
514,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
515,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
515,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
515,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
516,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
517,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
517,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
518,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
518,2,Deafness,Hearing losses,Hearing disorders,Ear,N
518,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
519,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
519,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
519,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
520,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
520,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
520,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
521,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
521,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
522,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
522,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
522,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
522,4,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
522,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
523,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
523,2,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
524,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
525,1,Small intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
526,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
526,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
527,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
527,2,Lung cancer metastatic,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
527,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
527,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
527,5,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
527,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
527,7,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
527,8,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
527,9,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
528,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
528,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
529,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
530,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
531,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
532,1,Abdominal operation,Abdominal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
532,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
532,3,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
532,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
532,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
532,6,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
532,7,Facial asymmetry,"Musculoskeletal and connective tissue deformities of skull, face and buccal cavity",Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
532,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
532,9,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
532,10,Gastrointestinal scarring,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
532,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
532,12,Intestinal strangulation,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
532,13,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
532,14,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
532,15,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
532,16,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
533,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
533,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
533,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
533,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
533,5,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
533,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
533,7,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
533,8,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
533,9,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
533,10,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
533,11,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
533,12,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
533,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
533,14,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
533,15,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
533,16,Onychalgia,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
533,17,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
533,18,Plantar erythema,Erythemas,Epidermal and dermal conditions,Skin,N
533,19,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
533,20,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
533,21,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
533,22,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
534,1,Vascular pain,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
535,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
535,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
535,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
535,4,Vascular pain,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
536,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
536,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
536,3,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
536,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
536,5,Device infusion issue,Device malfunction events NEC,Device issues,Prod,N
536,6,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
536,7,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
536,8,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
536,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
536,10,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
536,11,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
536,12,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
536,13,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
536,14,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
536,15,Myalgia,Muscle pains,Muscle disorders,Musc,N
536,16,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
536,17,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
536,18,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
536,19,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
536,20,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
536,21,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
536,22,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
537,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
537,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
537,3,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
537,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
537,5,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
537,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
537,7,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
537,8,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
537,9,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
537,10,Paraneoplastic rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
537,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
537,12,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
537,13,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
538,1,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
539,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
540,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
541,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
542,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
542,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
542,3,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
543,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
544,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
544,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
545,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
545,2,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
545,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
545,4,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
546,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
546,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
546,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
547,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
548,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
548,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
548,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
548,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
548,5,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
548,6,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
548,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
548,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
548,9,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
548,10,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
549,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
549,2,Cutaneous T-cell lymphoma stage IV,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
549,3,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
549,4,Histology abnormal,Histopathology procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
549,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
549,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
549,7,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
549,8,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
550,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
550,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
551,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
551,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
552,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
553,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
553,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
553,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
553,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
554,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
555,1,Aortic thrombosis,Aortic embolism and thrombosis,Embolism and thrombosis,Vasc,N
556,1,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
557,1,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
558,1,Neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
559,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
560,1,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
561,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
562,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
562,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
563,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
563,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
563,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
563,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
564,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
564,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
564,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
564,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
565,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
565,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
566,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
566,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
566,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
566,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
566,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
567,1,Brain teratoma,Central nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
567,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
568,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
569,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
570,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
570,2,Desmoplastic small round cell tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
570,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
570,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
570,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
570,6,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
570,7,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
570,8,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
570,9,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
570,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
570,11,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
570,12,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
571,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
571,2,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
571,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
571,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
572,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
572,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
572,3,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
572,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
572,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
572,6,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
572,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
572,8,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
572,9,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
572,10,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
572,11,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
572,12,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
572,13,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
572,14,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
572,15,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
572,16,Terminal agitation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
572,17,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
572,18,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
573,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
573,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
574,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
575,1,Vascular pain,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
576,1,Biliary sepsis,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
576,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
577,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
577,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
577,3,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
578,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
578,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
578,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
578,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
579,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
579,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
579,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
580,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
580,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
580,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
581,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
581,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
581,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
581,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
581,5,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
581,6,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
581,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
582,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
583,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
583,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
584,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
584,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
585,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
586,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
586,2,Desmoplastic small round cell tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
586,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
586,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
586,5,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
586,6,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
586,7,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
586,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
587,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
587,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
588,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
588,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
588,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
588,4,Necrotising scleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
588,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
588,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
589,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
589,2,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
589,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
590,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
590,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
591,1,Adult T-cell lymphoma/leukaemia recurrent,Adult T-cell lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,Y
591,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
591,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
592,1,Burkitt's lymphoma refractory,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
593,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
593,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
593,3,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
593,4,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
593,5,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
593,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
594,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
594,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
594,3,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
594,4,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
594,5,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
594,6,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
595,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
595,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
595,3,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
595,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
596,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
596,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
596,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
596,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
596,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
597,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
597,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
597,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
598,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
598,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
598,3,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
598,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
598,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
599,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
599,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
599,3,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
599,4,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
599,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
600,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
600,2,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
600,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
601,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
601,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
602,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
603,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
603,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
604,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
604,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
604,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
604,4,Panniculitis,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
604,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
604,6,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
605,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
605,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
606,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
606,2,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
606,3,Aortic thrombosis,Aortic embolism and thrombosis,Embolism and thrombosis,Vasc,N
606,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
606,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
606,6,Splenic infarction,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
607,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
608,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
608,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
608,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
608,4,Pseudocellulitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
608,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
609,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
610,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
610,2,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
611,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
611,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
611,3,Pseudocellulitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
611,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
611,5,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
611,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
612,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
612,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
612,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
612,4,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
613,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
613,2,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
613,3,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
613,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
613,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
613,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
614,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
615,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
615,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
615,3,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
616,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
617,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
617,2,Cutaneous T-cell lymphoma stage IV,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,Y
617,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
617,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
617,5,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
617,6,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
617,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
617,8,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
617,9,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
617,10,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
617,11,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
617,12,Unmasking of previously unidentified disease,General signs and symptoms NEC,General system disorders NEC,Genrl,N
618,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
618,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
618,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
618,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
618,5,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
619,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
620,1,Leiomyosarcoma metastatic,Leiomyosarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
620,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
620,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
621,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
622,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
623,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
623,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
624,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
625,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
626,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
626,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
626,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
627,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
627,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
627,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
627,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
627,5,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
627,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
627,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
628,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
628,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
628,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
628,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
628,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
628,6,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
628,7,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
628,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
628,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
628,10,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
628,11,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
628,12,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
629,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
629,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
629,3,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
629,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
629,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
629,6,Headache,Headaches NEC,Headaches,Nerv,N
629,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
629,8,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
629,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
629,10,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
629,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
630,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
630,2,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
630,3,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
630,4,Ovarian cancer recurrent,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
630,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
631,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
631,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
631,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
631,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
631,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
632,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
632,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
633,1,Oroticaciduria,Disorders of pyrimidine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
634,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
634,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
634,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
634,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
634,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
635,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
635,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
635,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
635,4,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
635,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
635,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
636,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
636,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
636,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
636,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
636,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
636,6,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
637,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
637,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
637,3,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
637,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
638,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
638,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
638,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
638,4,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
639,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
639,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
640,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
640,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
640,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
641,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
642,1,Infusion site thrombosis,Infusion site reactions,Administration site reactions,Genrl,N
643,1,Infusion site phlebitis,Infusion site reactions,Administration site reactions,Genrl,N
643,2,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
644,1,Catheter site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
644,2,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
645,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,Y
646,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
646,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
646,3,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
646,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
646,5,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
646,6,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
647,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
648,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
648,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
648,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
648,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
648,5,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
648,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
648,7,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
648,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
648,9,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
649,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
649,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
650,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
651,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
651,2,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
652,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
652,2,Ovarian cancer stage IV,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
653,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
654,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
654,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
654,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
654,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
655,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
656,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
657,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
658,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
659,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
659,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
659,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
659,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
659,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
659,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
659,7,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
659,8,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
659,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
659,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
659,11,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
660,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
660,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
660,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
660,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
660,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
660,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
660,7,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
661,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
661,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
661,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
661,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
662,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
662,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
663,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
663,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
663,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
664,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
664,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
664,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
665,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
666,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
666,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
666,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
666,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
667,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
667,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
668,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
669,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
670,1,Herpes simplex reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
671,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
671,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
672,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
673,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
674,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
674,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
675,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
675,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
675,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
676,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
676,2,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
677,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
677,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
677,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
677,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
678,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
679,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
679,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
679,3,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
679,4,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
679,5,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
680,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
680,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
680,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
680,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
680,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
680,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
681,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
681,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
681,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
681,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
681,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
681,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
681,7,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
681,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
682,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
683,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
683,2,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
683,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
683,4,PIK3CA-activated mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
684,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
684,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
684,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
684,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
685,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
685,2,Migraine,Migraine headaches,Headaches,Nerv,N
685,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
685,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
686,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
686,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
686,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
686,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
686,5,Headache,Headaches NEC,Headaches,Nerv,N
686,6,Headache,Headaches NEC,Headaches,Nerv,N
686,7,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
686,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
686,9,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
686,10,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
686,11,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
686,12,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
687,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
687,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
687,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
687,4,Headache,Headaches NEC,Headaches,Nerv,N
687,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
687,6,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
687,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
688,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
688,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
688,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
688,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
688,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
688,6,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
688,7,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
688,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
688,9,Oral mucosal roughening,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
689,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
689,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
689,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
690,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
690,2,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
690,3,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
690,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
690,5,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
690,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
690,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
690,8,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
691,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
691,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
691,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
692,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
692,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
693,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
693,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
694,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
694,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
694,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
694,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
694,5,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
694,6,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
694,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
694,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
694,9,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
694,10,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
695,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
696,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
696,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
697,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
697,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
697,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
697,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
697,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
697,6,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
697,7,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
698,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
699,1,Blood creatinine,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
699,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
699,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
700,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
700,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
700,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
701,1,Cholangiocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
701,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
701,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
702,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
702,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
702,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
703,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
703,2,Ovarian cancer recurrent,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
704,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
705,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
706,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
707,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
707,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
708,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
709,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
709,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
710,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
711,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
711,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
711,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
711,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
711,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
711,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
711,7,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
712,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
712,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
712,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
712,4,Headache,Headaches NEC,Headaches,Nerv,N
712,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
712,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
712,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
713,1,Infusion site thrombosis,Infusion site reactions,Administration site reactions,Genrl,N
714,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
714,2,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
714,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
714,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
714,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
714,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
714,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
714,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
714,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
714,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
715,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
715,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
716,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
716,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
716,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
717,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
718,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
718,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
718,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
718,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
718,5,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
718,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
718,7,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
718,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
718,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
718,10,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
719,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
720,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
720,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
721,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
721,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
721,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
721,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
721,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
721,6,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
721,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
721,8,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
722,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
722,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
723,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
723,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
724,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
724,2,Vaginal cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
725,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
726,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
727,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
727,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
727,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
727,4,Lipase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
727,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
728,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
729,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
729,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
729,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
729,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
730,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
730,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
731,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
731,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
731,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
732,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
732,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
733,1,Adenocarcinoma pancreas,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
733,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
733,3,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
733,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
733,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
733,6,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
733,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
733,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
733,9,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
733,10,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
733,11,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
733,12,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
733,13,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
734,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
734,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
734,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
735,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
735,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
736,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
736,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
736,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
737,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
737,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
737,3,Headache,Headaches NEC,Headaches,Nerv,N
737,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
738,1,Renal cancer metastatic,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
739,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
739,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
739,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
739,4,Tetany,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
740,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
740,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
741,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
741,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
741,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
741,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
741,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
741,6,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
741,7,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
742,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
742,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
743,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
743,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
744,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
744,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
744,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
744,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
745,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
745,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
746,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
747,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
747,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
748,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
748,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
748,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
749,1,Colon cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
749,2,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
749,3,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
749,4,Metastases to kidney,Metastases to specified sites,Metastases,Neopl,N
749,5,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
750,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
751,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
751,2,Vaginal cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
752,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
752,2,Vaginal cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
753,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
753,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
753,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
754,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
755,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
755,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
755,3,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
755,4,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
755,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
756,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
757,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
758,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
759,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
760,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
760,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
761,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
761,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
762,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
762,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
762,3,Gastrointestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
763,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
764,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
764,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
764,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
764,4,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
765,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
765,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
765,3,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
766,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
767,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
767,2,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
768,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
769,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
769,2,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
770,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
771,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
772,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
772,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
772,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
773,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
773,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
774,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
775,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
776,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
776,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
776,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
777,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
778,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
779,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
779,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
779,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
780,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
780,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
780,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
780,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
781,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
782,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
783,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
784,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
784,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
785,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
786,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
786,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
787,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
788,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
789,1,Bone scan abnormal,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
789,2,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
789,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
789,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
789,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
789,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
789,7,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
789,8,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
789,9,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
790,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
790,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
791,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
791,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
792,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
793,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
794,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
794,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
795,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
796,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
797,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
798,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
798,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
798,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
799,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
800,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
801,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
802,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
803,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
804,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
804,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
804,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
805,1,Adenoviral encephalitis,Adenoviral infections,Viral infectious disorders,Infec,N
805,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
805,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
805,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
805,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
805,6,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
805,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
806,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
806,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
807,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
807,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
807,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
808,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
809,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
810,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
811,1,Anal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
811,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
811,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
811,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
812,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
812,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
812,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
812,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
813,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
814,1,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
815,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
816,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
816,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
817,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
817,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
818,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
819,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
820,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
820,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
821,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
822,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
823,1,Asthenopia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
823,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
824,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
825,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
825,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
826,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
826,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
827,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
